Explainer-What Wegovy’s inclusion in Medicare price negotiation means for patients, company
(Reuters) – The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk’s blockbuster weight-loss drug Wegovy.Here’s what Wall Street analysts say about the inclusion: WHAT IT MEANS FOR PATIENTSThe potential for more aggressive price cuts would enable wider access to GLP-1 drugs – the same class of drugs as Ozempic and Wegovy – for people over the age of 65. Medicare prescription … Read more…